3 The 1999 NCI/Myriad MOU established ground rules permitting use of BRCA testing within a research institution and discounted testing for research clinical testing contracted to Myriad.4 According to a 2005 Lewin Group Report published for AdvaMed: An unintended effect of patents is that they may...